title: Immunoscoring breast cancer: TILs remember what they target.
authors.affiliation: Division of Experimental Therapeutics, Istituto Europeo di Oncologia, Milano, Italy giuseppe.curigliano@ieo.it.
authors.forename: G
authors.initials: G
authors.lastname: Curigliano
authors.affiliation: Division of Hematology/Medical Oncology and Cancer Biology, Mayo Clinic Cancer Center, Mayo Clinic, Jacksonville, FL, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Perez
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D054316:Biomarkers, Pharmacological; D014408:Biomarkers, Tumor; D005260:Female; D006801:Humans; D016246:Lymphocytes, Tumor-Infiltrating / Q000473:pathology*; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy* / Q000276:immunology*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D054316:Biomarkers, Pharmacological; D014408:Biomarkers, Tumor